Most Recent Articles by Jody A. Charnow, Editor
Findings support the use of a 5 grade-group system that more accurately reflects patient risk of adverse outcomes.
PCNL procedure rate nearly doubles over a 2-decade period, study finds.
PSA level declined by an average of 0.68 ng/mL in the treatment group.
Researchers found an adjusted 68% decreased risk of prostate cancer in men with IBD who used aminosalicylate.
Finding suggests that olfactory deficits may contribute to nutritional impairment in patients with chronic and end-stage renal disease.
More Articles by Jody A. Charnow, Editor
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)